VIEWPOINTS PharmaShots Interview: Prime Therapeutics’ Kelly Pokuta and April Kunze Share Insight on Medical Drug Management ProgramBySenior EditorAugust 3, 20210Comments
VIEWPOINTS PharmaShots Interview: Xencor’s Bassil I. Dahiyat Shares Insight on the US FDA’s Approval of COVID-19 Antibody Treatment Leveraging its TechnologyBySenior EditorAugust 3, 20210Comments
VIEWPOINTS PharmaShots Interview: Eli Lilly’s Dr. Lotus Mallbris Shares Insight on the Data of Taltz and Olumiant Presented at EULAR 2021BySenior EditorAugust 2, 20210Comments
VIEWPOINTS PharmaShots Interview: Guardant Health’s Justin Odegaard Shares Insight on the US FDA’s Approval of Guardant360 CDx for Amgen’s LumakrasBySenior EditorJuly 29, 20210Comments
VIEWPOINTS PharmaShots Interview: Dr. Krishnansu S. Tewari and Israel Lowy Share Insight on P-III Data of Libtayo Presented at ESMO Virtual PlenaryBySenior EditorJuly 28, 20210Comments
VIEWPOINTS PharmaShots Interview: Caris Life Sciences’ Dr. Spetzler Shares Insight on AI-Based MI FOLFOXai PredictorBySenior EditorJuly 27, 20210Comments
VIEWPOINTS PharmaShots Interview: Astellas’ Dr. Andrew Krivoshik Shares Insights on P-II FAST Study of ZolbetuximabBySenior EditorJuly 26, 20210Comments
INSIGHTS+ PharmaShots Celebrates Successful Accomplishment of Three YearsBySenior EditorJuly 25, 20210Comments
VIEWPOINTS PharmaShots Interview: BD’s Tony Ezell Shares Insights on the Collaboration with USATF to Provide COVID – 19 Testing for US AthletesBySenior EditorJuly 21, 20210Comments
